Cargando…
The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
Autores principales: | Cai, Changjing, Liu, Yihan, Zeng, Shan, Shen, Hong, Han, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486585/ https://www.ncbi.nlm.nih.gov/pubmed/34599870 http://dx.doi.org/10.1016/j.ymthe.2021.09.024 |
Ejemplares similares
-
Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2 (Delta) variant-infected patients
por: Hu, Zhiliang, et al.
Publicado: (2022) -
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021) -
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022) -
Inequalities associated with emergence of Delta SARS-CoV-2 variant of concern (B.1.617.2) in England: awareness for future variants
por: Leeman, D., et al.
Publicado: (2022) -
Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge
por: Adhikari, Emily H., et al.
Publicado: (2022)